To leverage all available biomedical research resources including technical expertise, hardware, and research mentors for the long-term goal of enhanced productivity and competitiveness, Xavier's RCMI will strive to build and expand strong, productive collaborations and partnerships both intra-institutionally and inter-institutionally. We have identified and assessed resources available to Xavier's research community and will focus on the research resources in collaborating institutions and the research strengths of Xavier's RCMI program, as well as taking advantage of the RCMI Translational Research Network (RTRN) for enhancing collaborative research among RCMI institutions. We propose the three specific aims in building extensive collaborations and partnerships:
Aim 1. Expand and enhance intra-institutional collaborations and partnerships among Xavier researchers by offering state-of-the-art core facilities and technical expertise that support and promote interdisciplinary research activities;
Aim 2. Strengthen collaborations and partnerships with RCMI institutions by effectively utilizing RTRN resources and the eagle-i database;
and Aim 3. Strengthen collaborations with Xavier's strategic partners at the Louisiana Cancer Research Consortium and the Louisiana Biomedical Research Network and develop new collaborations with the Louisiana Clinical and Translational Sciences Center. Through effective collaborations, Xavier's RCMI program will benefit from additional professional development resources such as mentors, increase funding opportunities such as multi-PI grant applications, and enhance research capabilities and competitiveness by having access to state-of-the-art technologies and instrumentation.

Agency
National Institute of Health (NIH)
Institute
National Institute on Minority Health and Health Disparities (NIMHD)
Type
Research Centers in Minority Institutions Award (G12)
Project #
5G12MD007595-07
Application #
8933972
Study Section
Special Emphasis Panel (ZMD1-MLS)
Project Start
2015-04-01
Project End
2019-03-31
Budget Start
2015-04-01
Budget End
2016-03-31
Support Year
7
Fiscal Year
2015
Total Cost
$1,098,827
Indirect Cost
$266,526
Name
Xavier University of Louisiana
Department
Type
DUNS #
020857876
City
New Orleans
State
LA
Country
United States
Zip Code
70125
Komati, Rajesh; Mitchell, Carl A; LeBeaud, Anastasia et al. (2018) Tenacic Acids: A New Class of Tenacious Binders to Metal Oxide Surfaces. Chemistry 24:14824-14829
Yao, Xin; Gray, Selena; Pham, Tri et al. (2018) Downregulation of Bit1 expression promotes growth, anoikis resistance, and transformation of immortalized human bronchial epithelial cells via Erk activation-dependent suppression of E-cadherin. Biochem Biophys Res Commun 495:1240-1248
Toro, Tasha B; Edenfield, Samantha A; Hylton, Brandon J et al. (2018) Chelatable trace zinc causes low, irreproducible KDAC8 activity. Anal Biochem 540-541:9-14
Echeverri, Margarita; Anderson, David; Nápoles, Anna María et al. (2018) Cancer Health Literacy and Willingness to Participate in Cancer Research and Donate Bio-Specimens. Int J Environ Res Public Health 15:
Schexnayder, Chandler; Broussard, Kiera; Onuaguluchi, Demitrius et al. (2018) Metformin Inhibits Migration and Invasion by Suppressing ROS Production and COX2 Expression in MDA-MB-231 Breast Cancer Cells. Int J Mol Sci 19:
Ponnapakkam, Tulasi; Saulsberry, Tyjah; Hill, Tarius et al. (2018) Inhibition of breast tumor growth in mice after treatment with ceramide analog 315. Anticancer Drugs 29:898-903
Al-Horani, Rami A; Afosah, Daniel K (2018) Recent advances in the discovery and development of factor XI/XIa inhibitors. Med Res Rev 38:1974-2023
Mei, Suyu; Flemington, Erik K; Zhang, Kun (2018) Transferring knowledge of bacterial protein interaction networks to predict pathogen targeted human genes and immune signaling pathways: a case study on M. tuberculosis. BMC Genomics 19:505
Aqeel, Salem M; Huang, Zhongyuan; Walton, Jonathan et al. (2018) Polyvinylidene Fluoride (PVDF)/Polyacrylonitrile (PAN)/Carbon Nanotube Nanocomposites for Energy Storage and Conversion. Adv Compos Hybrid Mater 1:185-192
Zheng, Shilong; Guo, Shanchun; Zhong, Qiu et al. (2018) Biocompatible Boron-Containing Prodrugs of Belinostat for the Potential Treatment of Solid Tumors. ACS Med Chem Lett 9:149-154

Showing the most recent 10 out of 244 publications